5-epi Emtricitabine
| Product Name | 5-epi Emtricitabine |
|---|---|
| Alternate Names | Emtricitabine Impurities, Impurities of Emtricitabine |
| CAT No. | CS-T-21592 |
| CAS No. | 145986-26-1 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 247.3 g/mol |
| Mol. For. | C8H10FN3O3S |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Emtricitabine |
| Therapeutic | Antiretroviral / Anti-HIV |
| Canonical Smiles | C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F |
| InchIKey | XQSPYNMVSIKCOC-PHDIDXHHSA-N |
| Inchl | InChI=1S/C8H10FN3O3S/c9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5/h1,5-6,13H,2-3H2,(H2,10,11,14)/t5-,6-/m1/s1 |
| IUPAC | 4-amino-5-fluoro-1-[(2R,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
5-epi Emtricitabine is a synthetic nucleoside analog that is used in the treatment of human immunodeficiency virus (HIV) infection. It is a potent inhibitor of the HIV reverse transcriptase enzyme and works by blocking the replication of the virus. The drug is also known as (-)-beta-L-2',3'-dideoxy-3'-thiacytidine and is marketed under the brand name Emtriva.
The chemical formula of 5-epi Emtricitabine is C8H10N3O3S and its molecular weight is 230.25 g/mol. The drug is a white to off-white crystalline powder that is soluble in water and slightly soluble in ethanol. The drug is administered orally and is available in tablet form.
The recommended dose of 5-epi Emtricitabine is 200 mg once daily in combination with other antiretroviral drugs. The drug has been approved by the US Food and Drug Administration (FDA) for the treatment of HIV infection in adults and children.
The drug has a good safety profile and is generally well-tolerated by patients. However, some side effects may occur, including nausea, diarrhea, headache, and fatigue. Rarely, severe allergic reactions may occur.
In conclusion, 5-epi Emtricitabine is an important medication in the treatment of HIV infection. Its efficacy and safety have been demonstrated in clinical trials, and it is widely used in combination with other antiretroviral drugs.
Get an Instant Quote
Related Compounds
Cis-cyclo-Emtricitabine | Emtricitabine FTU Impurity | Emtricitabine 5-fluorouracil analog | ent-Emtricitabine | Emtricitabine Dimer Impurity | Emtricitabine lactose adduct | Emtricitabine+Tenofovir FT3 | N-Acetyl O-Benzoyl 5-Epi Emtricitabine | Emtricitabine diastereomer(mixture) | Emtricitabine 6-Disulfide | Cyclic Diastereomeric Impurity Isomer-2 | Emtricitabine+Tenofovir FT2 | Emtricitabine+Tenofovir FT6 | Emtricitabine methyl ester | Emtricitabine Glycosamine | Emtricitabine Impurity 11 | Emtricitabine Impurity 6 | Emtricitabine Impurity 8 | Emtricitabine dioxolane | Emtricitabine Tenofovir Monosoproxil Dimer | Emtricitabine+Tenofovir FT4 | Emtricitabine Menthyl Ester(2S,5R Isomer) | Desamino Emtricitabine | Emtricitabine Impurity | Emtricitabine+Tenofovir FT1 | Emtricitabine Tenofovir Disoproxil Dimer | Emtricitabine+Des-Phenol Tenofovir Alfenamide Mixed Dimer | Emtricitabine Diastereomer | Emtricitabine (R)-sulphoxide | Emtricitabine Disulfide | conjugate Impurity of Tenofovir+Emtricitabine | Emtricitabine+Tenofovir FT5 | Emtricitabine F6 Impurity | Trans-cyclo-Emtricitabine | Emtricitabine (S)-sulphoxide | Emtricitabine Impurity 9 | Emtricitabine Racemic Mixture |